ICTC was established in 2004 to contribute to global efforts to eliminate trachoma by advocating for and supporting the implementation of the WHO-endorsed SAFE strategy.
ICTC members believe we can achieve more together as a group than if we were working as individual organizations. Observers include the World Health Organization (WHO), pharmaceutical, other private sector stakeholders and institutional and philanthropic funders. Membership is free to members and observers, who demonstrate a common commitment to accomplishing GET2020 objectives.
The coalition’s approach is aligned with the GET2020 Alliance's 2016 plan of action Eliminating trachoma: Accelerating Towards 2020, which outlines what needs to be done to scale up programs and strengthen health systems to achieve the global elimination of trachoma by the year 2020. This builds on earlier roadmaps, The end in sight: 2020 INSight, and WHO's 2011 Accelerating work to overcome the global impact of neglected tropical diseases - a roadmap for implementation, which is a comprehensive plan of control, elimination and eradication targets for 17 NTDs to be reached between 2012-2020.